Will the Secure Act make you more secure?

For full access, Log in or Subscribe Now and get 4 weeks free!

How big a deal is it that your 401(k) is now more likely to offer annuities alongside other investment options such as mutual funds and ETFs?

That’s a timely question, because the Secure Act—which takes effect on Jan. 1—makes it easier for your employer to include annuities as one of the investment options offered in its 401(k). Though employers up until now were theoretically able to offer annuities in their 401(k)s, few actually did so.

Read: Inheriting a parent’s IRA or 401(k)? Here’s how the Secure Act could create a disaster

• Actionable trading strategies
• Easy-to-follow guidance
• Weekly market navigational tool

Microbot Medical shares slide on share offering but are still up 104% on the week

Microbot Medical Inc. shares slid 20% Friday, after the medical device company announced a $10 million registered direct offering priced at-the-market at $10.50, a discount to its closing price Thursday of $13.98.

Proceeds of the deal will be used to develop the company’s self-cleaning shunt device for the treatment of hydrocephalus, or water on the brain, to develop its Liberty robotic system, to expand and develop additional applications deriving from its existing IP portfolio, and for working capital and other general corporate purposes.

The news caps a busy week for Microbot MBOT, -21.43%, which was founded in 2010 by Harel Gadot, Prof. Moshe Shoham, and Yossi Bornstein and is based in Hingham, Massachusetts.

On Monday, the company said it would reveal Liberty, which it says is the world’s first fully disposable robotic system for use in neurovascular, cardiovascular and peripheral vascular procedures, on Jan. 13 in San Francisco. The news sent its stock up more than 77% in one day, followed by a 61% gain on Tuesday.

Read now: Flexion Therapeutics shares soar after FDA approves change to label on knee pain treatment

On Wednesday, the stock price pulled back after the company announced a $9.59 million at-the-market offering, which was completed on Thursday.

The stock is still up 104% on the week, while the S&P 500 SPX, +0.08% has gained 0.6%.

News and analysis for those planning for or living in retirement

For full access, Log in or Subscribe Now and get 4 weeks free!

From MarketWatch:

Inheriting a parent’s IRA or 401(k)? Here’s how the SECURE Act could create a disaster: The new retirement law will require beneficiaries to withdraw assets within 10 years, but some may not even have access to the funds during that time.

When it comes to financial angst, boomers and millennials have more in common than they think: The generations sometimes act divided on personal finance matters, but they’re actually quite similar — especially when it comes to preparing for retirement.

What was the top stock of 2019? And should it be in your retirement account?: Investors often wonder what the best investments are, but what may be performing well today doesn’t necessarily mean it will do well tomorrow.

• Actionable trading strategies
• Easy-to-follow guidance
• Weekly market navigational tool

I’m so confused: How do I treat withdrawals from a Roth IRA?

For full access, Log in or Subscribe Now and get 4 weeks free!

Q.: I am unclear on how to treat withdrawals from a Roth IRA after I have made multiple partial conversions. I know each conversion starts its own “five-year-rule,” but I don’t see a clear way to know how to associate earnings with each conversion. I haven’t been able to find any information on how to treat earnings when multiple Roth conversions are made in the same Roth IRA. Can you shed any light on this for me?

— Chris

A.: Chris, it is not super simple, but is simpler than you fear. You do not have to associate earnings with any of the transactions in your Roth IRA. The accounting for this is done on Form 8606. The instructions for Form 8606 walk you through the process.

• Actionable trading strategies
• Easy-to-follow guidance
• Weekly market navigational tool

Microbot Medical shares slide on news of dilutive equity offering but remain up 99% on the week

Microbot Medical Inc. shares MBOT, -22.07% slid 24% Friday, after the medical device company announced a $10 million registered direct offering priced at-the-market at $10.50, a discount to its closing price Thursday of $13.98. Proceeds of the deal will be used to develop the company’s self cleaning shunt device for the treatment of hydrocephalus, or water on the brain, to develop its LIBERTY robotic system, to expand and develop additional applications deriving from its existing IP portfolio, and for working capital and other general corporate purposes. The news caps a busy week for Microbot, which was founded in 2010 by Harel Gadot, Prof. Moshe Shoham, and Yossi Bornstein and is based in Hingham, Massachusetts. The company conducted a previous $9.59 million ATM offering on Thursday. On Monday, it said it would reveal Liberty, which it says is the world’s first fully disposable robotic system for use in neurovascular, cardiovascular and peripheral vascular procedures. on Jan. 13 in San Francisco. The news sent its stock up more than 70%. The stock remains up 99% on the week.